Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Not applicable Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20091
20122
20132
20141
20161
20183
20193
20206
20215
20226
20234
20246
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status13
Recruiting8
Active, not recruiting6
Not yet recruiting3
Enrolling by invitation2
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
Chinese Academy of Medical Sciences2
OHSU Knight Cancer Institute2
Peking University2
RenJi Hospital2
Shanghai Zhongshan Hospital2
The First Affiliated Hospital with Nanjing Medical University2
University of California, San Francisco2
Xijing Hospital of Digestive Diseases2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma49
Esophageal Neoplasms12
Colorectal Neoplasms4
Carcinoma, Hepatocellular2
Esophageal Diseases2
Gastroesophageal Reflux2
Gastrointestinal Neoplasms2
Stomach Neoplasms2
Anus Neoplasms1
Barrett Esophagus1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.